The treatment protocol for hyperglycemia differed between studies even though the initial reduction in parenteral glucose intakes and, subsequently, the beginning of insulin therapy was common: the minimum glucose infusion was reported in three studies as ranging between 5 and 7 mg/kg/min [19,28,30], while the starting dose of insulin was described as being in the range of 0.01–0.5 IU/kg/h in three other studies [19,26,30]. The gene discussed is INS; the disease is Hyperglycemia.